The US president is angry with the chair of the Federal Reserve over interest rates. He’s applying a lot of pressure on Jay Powell to lower them or leave his job. The FT’s Claire Jones and Adam Posen, president of the Peterson Institute for International Economics, break down what will happen if Trump succeeds in either of those goals.

Mentioned in this podcast:

Email Marc with your questions (Marc.Filippino@ft.com)

Donald Trump and Jay Powell spar as US president visits Federal Reserve

Why a $2.5bn refurbishment of the Federal Reserve could be Jay Powell’s undoing

Donald Trump brings war against the Fed to Jay Powell’s home turf

Sign up for the FT’s Swamp Notes newsletter here

Swamp Notes is produced by Henry Larson and mixed by Samantha Giovinco. We get help from Lauren Fedor. The FT’s acting co head of audio is Topher Forhecz. Special thanks to Pierre Nicholson.

CREDIT: CNBC

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Zohran Mamdani shocked a city, and his own political party, when he soundly defeated his influential rival in New York City’s Democratic mayoral primary election. Now, as the second leg of the race reveals itself, Mamdani has a chance to redefine how the party talks about its critical issues. The FT’s Rana Foroohar and the American Enterprise Institute’s Michael Strain discuss what the party can learn from its nominee and what it would mean if he won.

Mentioned in this podcast:

Email Marc with your questions (Marc.Filippino@ft.com)

New York’s Zohran Mamdani wins over some of the city’s business elite

Make America affordable again

Zohran Mamdani is wrong — of course billionaires should exist

Sign up for the FT’s Swamp Notes newsletter here

Swamp Notes is produced by Henry Larson and mixed by Samantha Giovinco. We had help from Lauren Fedor. The FT’s acting co-head of audio is Topher Forhecz. Special thanks to Pierre Nicholson.

CREDIT: Zohran Mamdani For NYC, NBC News, NPR, NY1, CNBC

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

When US President Donald Trump threatened 200 per cent tariffs on foreign-made pharmaceuticals, investors responded like it was a placebo. It’s the latest spat between drugmakers and an administration that share a complicated relationship. The FT’s Hannah Kuchler and Patrick Temple-West explain why Trump and Big Pharma aren’t getting along, and what that prescribes for the future of the industry.

Mentioned in this podcast:

Email Marc your questions (Marc.Filippino@ft.com)

Investors shrug off Donald Trump’s 200% tariff on pharma

The looming ‘patent cliff’ facing Big Pharma

Sign up for the FT’s Swamp Notes newsletter here

Swamp Notes is produced by Henry Larson. Topher Forhecz is the FT’s executive producer. The FT’s acting co-head of audio is Topher Forhecz. Special thanks to Pierre Nicholson.

CREDIT: The White House, Roll Call

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.